Precision BioSciences sells 25,000 shares at $12 to management in private placement

PRECISION BIOSCIENCES INC

Gross proceeds ~$300k from sale of 25,000 shares at $12.00/share (13.5% premium to prior day close).
CEO Michael Amoroso and CFO Alex Kelly each purchase 8,334 shares ($100k); GC and CRO purchase 833 shares each.
Net proceeds to be used to fund ongoing research and development initiatives; close expected May 8, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.